Trial
NCT00616642
Rosiglitazone in Treating Patients With Pituitary Tumors
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
National Institutes of Health (NIH)
Condition
Brain and Central Nervous System Tumors
Intervention
rosiglitazone maleate
Why stopped
low patient recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-08-14